mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.02 |
mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
BIRB 0796 |
GDSC1000 |
pan-cancer |
AAC |
0.078 |
0.02 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.03 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
-0.1 |
0.03 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.03 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.03 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |